These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9771835)

  • 1. Effect of complement inhibition with soluble complement receptor 1 on pig allotransplant lung function.
    Pierre AF; Xavier AM; Liu M; Cassivi SD; Lindsay TF; Marsh HC; Slutsky AS; Keshavjee SH
    Transplantation; 1998 Sep; 66(6):723-32. PubMed ID: 9771835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total complement inhibition: an effective strategy to limit ischemic injury during coronary revascularization on cardiopulmonary bypass.
    Lazar HL; Bao Y; Gaudiani J; Rivers S; Marsh H
    Circulation; 1999 Sep; 100(13):1438-42. PubMed ID: 10500046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement inhibition by soluble complement receptor type 1 improves microcirculation after rat liver transplantation.
    Lehmann TG; Koeppel TA; Kirschfink M; Gebhard MM; Herfarth C; Otto G; Post S
    Transplantation; 1998 Sep; 66(6):717-22. PubMed ID: 9771834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil adhesion and complement inhibition prolongs survival of cardiac xenografts in discordant species.
    Zehr KJ; Herskowitz A; Lee PC; Kumar P; Gillinov AM; Baumgartner WA
    Transplantation; 1994 Mar; 57(6):900-6. PubMed ID: 8154039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement inhibition by soluble complement receptor type 1 fails to moderate cerulein-induced pancreatitis in the rat.
    Weiser MR; Gibbs SA; Moore FD; Hechtman HB
    Int J Pancreatol; 1996 Apr; 19(2):129-34. PubMed ID: 8723555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement activation as a cause for primary graft failure in an isogeneic rat model of hypothermic lung preservation and transplantation.
    Naka Y; Marsh HC; Scesney SM; Oz MC; Pinsky DJ
    Transplantation; 1997 Nov; 64(9):1248-55. PubMed ID: 9371664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A soluble deletion mutant of the human complement receptor type 1, which lacks the C4b binding site, is a selective inhibitor of the alternative complement pathway.
    Scesney SM; Makrides SC; Gosselin ML; Ford PJ; Andrews BM; Hayman EG; Marsh HC
    Eur J Immunol; 1996 Aug; 26(8):1729-35. PubMed ID: 8765013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. sCR1sLe ameliorates ischemia/reperfusion injury in experimental lung transplantation.
    Stammberger U; Hamacher J; Hillinger S; Schmid RA
    J Thorac Cardiovasc Surg; 2000 Dec; 120(6):1078-84. PubMed ID: 11088029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble complement receptor-1 protects heart, lung, and cardiac myofilament function from cardiopulmonary bypass damage.
    Chai PJ; Nassar R; Oakeley AE; Craig DM; Quick G; Jaggers J; Sanders SP; Ungerleider RM; Anderson PA
    Circulation; 2000 Feb; 101(5):541-6. PubMed ID: 10662752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the complement cascade by soluble complement receptor type 1. Protective effect in experimental liver ischemia and reperfusion.
    Chávez-Cartaya RE; DeSola GP; Wright L; Jamieson NV; White DJ
    Transplantation; 1995 Apr; 59(7):1047-52. PubMed ID: 7709442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous complement (C) inhibition using soluble C receptor type 1 (sCR1): effect on hyperacute rejection (HAR) of pig-to-primate cardiac xenografts.
    Pruitt Sk; Bollinger RR; Collins BH; Marsh HC; Levin JL; Rudolph AR; Baldwin WM; Sanfilippo F
    Transplant Proc; 1996 Apr; 28(2):756. PubMed ID: 8623382
    [No Abstract]   [Full Text] [Related]  

  • 12. Soluble complement receptor type 1 inhibited the systemic organ injury caused by acid instillation into a lung.
    Nishizawa H; Yamada H; Miyazaki H; Ohara M; Kaneko K; Yamakawa T; Wiener-Kronish J; Kudoh I
    Anesthesiology; 1996 Nov; 85(5):1120-8. PubMed ID: 8916830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement inhibition with soluble complement receptor type 1 in cardiopulmonary bypass.
    Gillinov AM; DeValeria PA; Winkelstein JA; Wilson I; Curtis WE; Shaw D; Yeh CG; Rudolph AR; Baumgartner WA; Herskowitz A
    Ann Thorac Surg; 1993 Mar; 55(3):619-24. PubMed ID: 8383955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenografts.
    Pruitt SK; Kirk AD; Bollinger RR; Marsh HC; Collins BH; Levin JL; Mault JR; Heinle JS; Ibrahim S; Rudolph AR
    Transplantation; 1994 Feb; 57(3):363-70. PubMed ID: 8108871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of inhibition of complement by sCR1 on hepatic microcirculation after warm ischemia.
    Lehmann TG; Koeppel TA; Münch S; Heger M; Kirschfink M; Klar E; Post S
    Microvasc Res; 2001 Nov; 62(3):284-92. PubMed ID: 11678631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of repetitive high-dose treatment with soluble complement receptor type 1 and cobra venom factor on discordant xenograft survival.
    Candinas D; Lesnikoski BA; Robson SC; Miyatake T; Scesney SM; Marsh HC; Ryan US; Dalmasso AP; Hancock WW; Bach FH
    Transplantation; 1996 Aug; 62(3):336-42. PubMed ID: 8779679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of complement inhibition with soluble complement receptor-1 on vascular injury and inflammation during renal allograft rejection in the rat.
    Pratt JR; Hibbs MJ; Laver AJ; Smith RA; Sacks SH
    Am J Pathol; 1996 Dec; 149(6):2055-66. PubMed ID: 8952538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of soluble complement receptor type 1 on reperfusion edema and neutrophil migration after lung allotransplantation in swine.
    Schmid RA; Zollinger A; Singer T; Hillinger S; Leon-Wyss JR; Schöb OM; Høgåsen K; Zünd G; Patterson GA; Weder W
    J Thorac Cardiovasc Surg; 1998 Jul; 116(1):90-7. PubMed ID: 9671902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble complement receptor type 1 inhibits the complement pathway and prevents contractile failure in the postischemic heart. Evidence that complement activation is required for neutrophil-mediated reperfusion injury.
    Shandelya SM; Kuppusamy P; Herskowitz A; Weisfeldt ML; Zweier JL
    Circulation; 1993 Dec; 88(6):2812-26. PubMed ID: 8252695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the complement system in antigen-induced bronchoconstriction and changes in blood pressure in the guinea pig.
    Regal JF; Fraser DG; Toth CA
    J Pharmacol Exp Ther; 1993 Nov; 267(2):979-88. PubMed ID: 8246173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.